0001209191-17-053232.txt : 20170918
0001209191-17-053232.hdr.sgml : 20170918
20170918210603
ACCESSION NUMBER: 0001209191-17-053232
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170914
FILED AS OF DATE: 20170918
DATE AS OF CHANGE: 20170918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUGGAN ROBERT W
CENTRAL INDEX KEY: 0001055919
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 171090998
MAIL ADDRESS:
STREET 1: 611 SOUTH FORT HARRISON AVE
STREET 2: SUITE 306
CITY: CLEARWATER
STATE: FL
ZIP: 33756
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-906-4600
MAIL ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-14
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001055919
DUGGAN ROBERT W
611 S. FORT HARRISON AVE., SUITE 306
CLEARWATER
FL
33756
0
0
1
0
Common Stock
2017-09-14
4
P
0
50300
11.6622
A
3437994
D
Common Stock
2017-09-14
4
P
0
30050
12.774
A
3468044
D
Common Stock
2017-09-14
4
P
0
53820
13.9007
A
3521864
D
Common Stock
2017-09-14
4
P
0
47450
14.5697
A
3569314
D
Common Stock
2017-09-15
4
P
0
71598
14.3791
A
3640912
D
Common Stock
2017-09-15
4
P
0
125000
15.7047
A
3765912
D
Common Stock
2017-09-15
4
P
0
500
16.215
A
3766412
D
Common Stock
2017-09-18
4
P
0
23703
15.1155
A
3790115
D
Common Stock
2017-09-18
4
P
0
7497
15.4962
A
3797612
D
Common Stock
35000
I
See footnote
This is the weighted average purchase price of the shares, which ranged from $11.1366 to $12.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $12.14 to $13.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $13.255 to $14.25 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $14.265 to $15.01 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $14.16 to $15.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $15.18 to $16.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $16.195 to $16.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $14.4015 to $15.3999 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $15.4463 to $15.569 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.
Brian Dow, as Attorney-in-Fact for Robert W. Duggan
2017-09-18